综合性蛋白质基因组分析为胆囊癌提供了分子洞察力和临床意义

Zile Fu1, Yuanli Song2, Fen Liu3

  • 1Department of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Fudan University, Shanghai 200032, China.

Cancer cell
|January 9, 2026
PubMed
概括

这项研究揭示了胆囊癌 (GBC) 的关键分子驱动因素,包括TP53和ELF3突变以及ErbB2放大,提供了新的治疗点. 蛋白质基因组分析确定了肝脏侵袭的亚型和代谢驱动因素.